Grace Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | $312K | Hold |
1,300
| – | – | 0.19% | 112 |
|
2021
Q3 | $351K | Buy |
1,300
+200
| +18% | +$54K | 0.22% | 115 |
|
2021
Q2 | $381K | Sell |
1,100
-250
| -19% | -$86.6K | 0.26% | 101 |
|
2021
Q1 | $378K | Hold |
1,350
| – | – | 0.24% | 113 |
|
2020
Q4 | $331K | Hold |
1,350
| – | – | 0.21% | 117 |
|
2020
Q3 | $382K | Sell |
1,350
-900
| -40% | -$255K | 0.3% | 85 |
|
2020
Q2 | $602K | Hold |
2,250
| – | – | 0.52% | 55 |
|
2020
Q1 | $712K | Sell |
2,250
-500
| -18% | -$158K | 0.7% | 46 |
|
2019
Q4 | $816K | Sell |
2,750
-400
| -13% | -$119K | 0.67% | 36 |
|
2019
Q3 | $733K | Buy |
3,150
+400
| +15% | +$93.1K | 0.74% | 33 |
|
2019
Q2 | $643K | Hold |
2,750
| – | – | 0.31% | 85 |
|
2019
Q1 | $650K | Sell |
2,750
-700
| -20% | -$165K | 0.25% | 103 |
|
2018
Q4 | $1.04M | Buy |
3,450
+700
| +25% | +$211K | 0.48% | 69 |
|
2018
Q3 | $973K | Sell |
2,750
-6,500
| -70% | -$2.3M | 0.38% | 69 |
|
2018
Q2 | $798K | Buy |
9,250
+4,546
| +97% | +$392K | 0.3% | 82 |
|
2018
Q1 | $1.25M | Buy |
4,704
+2,104
| +81% | +$561K | 0.67% | 48 |
|
2017
Q4 | $828K | Buy |
+2,600
| New | +$828K | 0.29% | 63 |
|